These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Interaction of drugs inhibiting different steps in the synthesis of DNA. Grindey GB; Nichol CA Cancer Res; 1972 Mar; 32(3):527-31. PubMed ID: 4258632 [No Abstract] [Full Text] [Related]
3. The concentration-dependent nature of in vitro amphotericin B-itraconazole interaction against Aspergillus fumigatus: isobolographic and response surface analysis of complex pharmacodynamic interactions. Meletiadis J; te Dorsthorst DT; Verweij PE Int J Antimicrob Agents; 2006 Nov; 28(5):439-49. PubMed ID: 17055706 [TBL] [Abstract][Full Text] [Related]
4. The design of pharmacological experiments using unbiased models of agonist-antagonist interaction. Vere DW J Pharmacol Exp Ther; 1978 Jun; 205(3):617-23. PubMed ID: 660533 [TBL] [Abstract][Full Text] [Related]
5. Towards a mechanism-based analysis of pharmacodynamic drug-drug interactions in vivo. Jonker DM; Visser SA; van der Graaf PH; Voskuyl RA; Danhof M Pharmacol Ther; 2005 Apr; 106(1):1-18. PubMed ID: 15781119 [TBL] [Abstract][Full Text] [Related]
6. A system of models for the action of drugs applied singly or jointly to biological organisms. Ashford JR; Cobby JM Biometrics; 1974 Mar; 30(1):11-31. PubMed ID: 4813377 [No Abstract] [Full Text] [Related]